Point72 Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Point72 Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-6,196	Closed	-$460K	–	1772
2022 Q2	$460K	Buy	+6,196	New	+$465K	﹤0.01%	1202
2022 Q1	–	Sell	-40,000	Closed	-$3.69M	–	1419
2021 Q4	$4.48M	Buy	+40,000	New	+$4.82M	0.02%	698
2017 Q1	–	Sell	-63,500	Closed	-$4.26M	–	985
2016 Q4	$3.76M	Sell	63,500 -89,000	-58%	-$5.49M	0.03%	475
2016 Q3	$10.1M	Sell	152,500 -38,500	-20%	-$2.38M	0.07%	279
2016 Q2	$10.3M	Buy	+191,000	New	+$10.5M	0.07%	296

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Point72 Asset Management's XBI Position: Q3 2022 in Review

Point72 Asset Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2022, closing a stake of 6,196 shares — an estimated $460K sold.

Point72 Asset Management first reported a position in XBI in Q2 2016 and held it in 5 quarters. The position peaked at $10.3M in Q2 2016. 704 funds tracked by Wall St. Rank hold XBI as of Q3 2022.

Point72 Asset Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2022 after selling out during the quarter.
Point72 Asset Management sold 6,196 State Street SPDR S&P Biotech ETF shares in Q3 2022, an estimated $460K.
Point72 Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2016 and held it in 5 quarters.
Point72 Asset Management's State Street SPDR S&P Biotech ETF position peaked at $10.3M in Q2 2016.
704 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2022.

Based on Point72 Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.